MEPSGEN, developing new medicines using human organs-on-chips technology
2023-02-13
YongTae Kim(CEO of MEPSGEN) is attending 'MPS and Beyond symposium'
2023-02-08
Online seminar : 'Microphysiological Barrier System for Drug Development'
2023-02-06
2022 13th Korean Tissue Engineering and Regenerative Medicine Society.
2022-12-09
MEPSGEN is attending the 2022 Korean BioChip Society Fall Conference in Jeju, November 2-4.
2022-11-02
[1st block of Bio] Sharing the interview of Robert Langer, MIT professor.
2022-10-24
Organ-on-a-chip will surely play critical roles in predictive clinical trials, including faster time to drug discovery
2022-10-20
MEPSGEN_2022 KAAT Conference: 3D MPS and Organoid meet together.
2022-09-02
Hoon Suk Rho(CTO of MEPSGEN) presenting MEPSGEN at BIOPLUS INTERPHEX KOREA 2022, COEX.
2022-08-02
MEPS-BBB was selected for Blood-brain barrier research model at Goizueta Alzheimer’s Disease Research Center, Emory University.
2022-07-15
MEPSGEN Adds $7.94 Million to Series B
2022-07-14
‘Organ-on-a-chip’, capable of replacing 500 million laboratory animals per year... venture investment, showed movements.
2022-07-13
MEPSGEN, “Spur the development of new drugs based on human organ on a chip”
MEPSGEN-OSONG Medical Innovation Foundation, Discussed about mutual cooperation and confirmed foundation infrastructure.
2022-07-06
MEPSGEN, Participating Asia's largest global startup fair "Nextrise, Seoul 2022"
2022-06-16
[KOREA PHARM & BIO 2022] Mepsgen introduces its booth at KOREA PHARM & BIO 2022
2022-06-13
[YOUTUBE] MEPSGEN, presenting 3D Organ-on-a-chip at Bio Korea 2022. "Possible to overcome the limitations of the 2D platform"
2022-06-03
MEPSGEN, presenting 3D Organ-on-a-chip at Bio Korea 2022. "Possible to overcome the limitations of the 2D platform"
2022-05-11
[BIO KOREA 2022] Mepsgen introduces its booth at BIO KOREA 2022
MEPSGEN became a new member of Korea Bio Technology Industry Organization (KOREABIO)
2022-04-20
